Skip to main content

Publications

106 publications

Active

5 grants
  • MPI
    Project 1: Molecular Determinants of GIST Pathogenesis
    NCI · 2018–2029 · via NIH RePORTER
    P50CA217694-08
  • PI
    Clinical Scholars Biomedical Research Training Program
    NCI · 1985–2028 · via NIH RePORTER
    T32CA009512-37
  • PI
    Harnessing double stranded-RNA (dsRNA)-response and anti-tumor effect in PRC2-inactivated cancer
    NCI · 2023–2028 · via NIH RePORTER
    R01CA280657-04
  • PI
    Phase II Study of ASTX727 in Patients with PRC2 loss Malignant Peripheral Nerve Sheath Tumor (MPNST)
    NIH · 2022–2027 · via NIH RePORTER
    R01FD007544-03
  • PI
    Understanding and targeting MAPK pathway activation in NF1-deficient malignant peripheral nerve sheath tumor (MPNST)
    NCI · 2021–2026 · via NIH RePORTER
    U01CA252048-05
Completed grants (5)
  • MPI
    Epigenetic mechanisms of transcriptional activation of a novel oncogenic ALK variant in cancer
    NCI · 2018–2024 · via NIH RePORTER
    R01CA228216-05
  • PI
    Phase2 trial of MEK162 & imatinib combined therapy in GIST, IND119794(09/20/2013)
    NIH · 2017–2021 · via NIH RePORTER
    R01FD005731-04
  • PI
    An integrative approach to target lineage-specific oncogenic transcription factor
    NCI · 2012–2017 · via NIH RePORTER
    DP2CA174499-01
  • PI
    Elucidating the roles of ETV1 in the pathogenesis of GIST
    NCI · 2011–2016 · via NIH RePORTER
    K08CA151660-05
  • PI
    Elucidating Mechanisms of Histone H2B Dynamic Modification in Mammalian Apoptosis
    NCI · 2007–2009 · via NIH RePORTER
    F32CA130372-02